United States · FDA National Drug Code directory
Risedronate Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-3098_641c2a59-be2b-4246-8990-b7bf563012be
- Product NDC
- 0093-3098
- Form
- TABLET, FILM COATED
- Composition / generic term
- Risedronate Sodium
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150601
- Source listing expiry
- 20271231
Source-listed ingredients
- RISEDRONATE SODIUM MONOHYDRATE — 35 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 12 BLISTER PACK in 1 CARTON (0093-3098-29) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0093-3098-19) · 0093-3098-29
- 4 BLISTER PACK in 1 CARTON (0093-3098-44) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0093-3098-19) · 0093-3098-44
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →